Broad Institute, Inc.

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Dan Shore, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Broad Institute, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. 10%+ Owner Common Stock 809,784 $8,097,840 $10.00 21 Jun 2021 Direct

Insider Reports Filed by Broad Institute, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERV Verve Therapeutics, Inc. 21 Jun 2021 1 $0 4 10%+ Owner 23 Jun 2021, 18:13
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 19:18